Market Tracker

05/30 12:30pm ET

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

99.43
Delayed Data
As of May 27
 -0.64 / -0.64%
Today’s Change
52.00
Today|||52-Week Range
156.93
-11.99%
Year-to-Date
Better Buy: Novavax, Inc. vs. Pfizer Inc.
1:02pm / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Medivation, Anacor, Aduro, Trevena and Tetraphase
May 20 / Zacks.com - Paid Partner Content
Buy Pfizer, Chevron, Newell Brands and Enjoy the Profits
May 25 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, T...
May 19 / Zacks.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May 17 / Zacks.com - Paid Partner Content
Stock Market News for May 23, 2016
May 23 / Zacks.com - Paid Partner Content
Pfizer to Buy Anacor, Add Eczema Treatment to Portfolio
May 17 / Zacks.com - Paid Partner Content
Here's What Pfizer's Telling Us About Biotech M&A
May 21 / MotleyFool.com - Paid Partner Content
Apple Inc. and Anacor Pharmaceuticals Inc. Soar As Stocks Jump
May 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close100.07
Today’s open99.76
Day’s range99.17 - 99.99
Volume2,204,074
Average volume (3 months)1,620,412
Market cap$4.5B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+32.52%
Earnings growth (this year)+4.86%
Earnings growth (next 5 years)+62.80%
Revenue growth (last year)+298.12%
P/E ratioNM
Price/Sales60.28
Price/Book85.13

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.36+0.79%
GRFSGrifols SA+0.13+0.81%
ACADACADIA Pharmaceutica...+0.71+2.03%
UTHRUnited Therapeutics ...+0.63+0.54%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$82.4M
Annual profit (last year)-$61.2M
Net profit margin-74.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Executive Vice President
Graeme Bell
Corporate headquarters
Palo Alto, California

Forecasts